InsiderTrades

Form 4 for MRNA Moderna

Accepted 2023-01-20 00:00:00 ET · period of report 2023-01-18 · accession 0001127602-23-001932 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-01-20 2023-01-18+ MRNA Bancel Stephane CEO, Dir S - Sale+OE $195.01 -80.0K 5.41M -1% -$15.60M
DM 2023-01-20 2023-01-18+ MRNA Bancel Stephane CEO, Dir M - OptEx $0.99 +80.0K 5.45M +1% +$79.2K
DM 2023-01-20 2023-01-18+ MRNA Bancel Stephane CEO, Dir M - OptEx $0.00 -80.0K 1.79M -4% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-01-18 S D 15,554 $197.58 5,420,623 D — — (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $197.19 to $198.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
2 Common Common Stock 2023-01-18 S D 851 $198.46 5,419,772 D — — (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $198.24 to $198.99. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
3 Common Common Stock 2023-01-18 S D 5,948 $196.84 5,436,177 D — — (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $196.18 to $197.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
4 Common Common Stock 2023-01-18 S D 9,821 $195.31 5,442,125 D — — (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.15 to $196.15. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
5 Common Common Stock 2023-01-18 M A 40,000 $0.99 5,451,946 D — —
6 Common Common Stock 2023-01-19 S D 2,704 $193.61 5,411,946 D — — (F16) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $193.44 to $193.97. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
7 Common Common Stock 2023-01-18 S D 1,475 $199.94 5,418,297 D — — (F6) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.47 to $200.23. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
8 Common Common Stock 2023-01-18 S D 1,501 $200.82 5,416,796 D — — (F7) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.48 to $201.48. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
9 Common Common Stock 2023-01-18 S D 900 $202.20 5,415,896 D — — (F8) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.62 to $202.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
10 Common Common Stock 2023-01-18 S D 1,020 $203.06 5,414,876 D — — (F9) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.63 to $203.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
11 Common Common Stock 2023-01-18 S D 300 $204.13 5,414,576 D — — (F10) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.69 to $204.69. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
12 Common Common Stock 2023-01-18 S D 1,758 $205.20 5,412,818 D — — (F11) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.78 to $205.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
13 Common Common Stock 2023-01-18 S D 872 $206.50 5,411,946 D — — (F12) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $206.14 to $207.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
14 Common Common Stock 2023-01-19 M A 40,000 $0.99 5,451,946 D — —
15 Common Common Stock 2023-01-19 S D 9,341 $191.16 5,442,605 D — — (F13) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $190.41 to $191.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
16 Common Common Stock 2023-01-19 S D 18,438 $191.88 5,424,167 D — — (F14) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $191.42 to $192.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
17 Common Common Stock 2023-01-19 S D 9,517 $192.84 5,414,650 D — — (F15) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.43 to $193.43. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
18 Derivative Stock Option (Right to Buy) 2023-01-18 M D 40,000 $0.00 1,827,155 D $0.99 · — to 2023-08-19 40,000 Common Stock (F19) This option is fully vested and exercisable.
19 Derivative Stock Option (Right to Buy) 2023-01-19 M D 40,000 $0.00 1,787,155 D $0.99 · — to 2023-08-19 40,000 Common Stock (F19) This option is fully vested and exercisable.